The Plasma Glycome Differences Between Women with PCOS and Healthy Controls
International Journal of Molecular Sciences · 03.03.2026 · 27 (5) · 2350
DOI: 10.3390/ijms27052350 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.03.2026. Verfasst von Madison Holman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ecology and Evolutionary Biology, School of Science, University of Arizona, Tucson, AZ 85721, USA. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Polysaccharides. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: No funding to report.
Abstract (Originalsprache)
While PCOS research has extensively explored genomic, transcriptomic, proteomic, and metabolomic milieus, our study examines the plasma glycome, comparing women with PCOS to age-matched healthy controls. In this observational study, n = 47 women with PCOS were screened and enrolled at the UC Davis Health campus; the comparator group constituted of n = 25 age-matched healthy women. During a study visit, body weight and body composition were measured, and fasted plasma samples were obtained to measure glucose, insulin, circulating lipids, and leptin, among other parameters, in both groups. In addition, in the PCOS group, circulating androgens and other endocrine hormones were measured. The plasma glycome was measured using a UHPLC-MS protocol. As expected, women with PCOS had higher body weight (p < 0.01), body fat (p = 0.004), fasting leptin (p = 0.01), insulin (p = 0.003), and glucose (p = 0.004). Hybrid-type glycans were reduced (p = 0.019), while tetraantennary (glycans with four branches) were modestly increased (p = 0.05) in women with PCOS compared to healthy controls. SVEM–LASSO (bootstrapped) regression models further supported a higher tetraantennary and lower hybrid glycan profile as representative of women with PCOS (AUROC: 0.81, accuracy: 82), even when adjusted for body weight (AUROC: 0.89, accuracy: 80) and body fat mass (AUROC: 0.89, accuracy: 86). Furthermore, in women with PCOS, total testosterone was positively correlated with tetraantennary glycans (r = 0.322, p = 0.029). We report novel findings of elevated tetraantennary and reduced hybrid-type N-glycans in PCOS, and a potential association between circulating androgens and protein glycosylation. Given the pilot nature of this study, larger cohort investigations are required to validate these observations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ecology and Evolutionary Biology, School of Science, University of Arizona, Tucson, AZ 85721, USA.
- Department of Physiology, College of Medicine, University of Arizona, Tucson, AZ 85721, USA.
- School of Nutritional Sciences and Wellness, University of Arizona, Tucson, AZ 85721, USA.
- Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, 2333 Leiden, The Netherlands.
- Department of Medicine, University of California Davis, Sacramento, CA 95616, USA.
ORCID-Profile: Sophie Jie Li, Mary M Ahern, L Renee Ruhaak
Förderung
- No funding to report
Zitieren
APA
Holman, M., Li, S. J., Ahern, M. M., Ruhaak, L. R., Karakas, S., & Krishnan, S. (2026). The Plasma Glycome Differences Between Women with PCOS and Healthy Controls. International Journal of Molecular Sciences, 27(5), 2350. https://doi.org/10.3390/ijms27052350
Vancouver
Holman M, Li SJ, Ahern MM, Ruhaak LR, Karakas S, Krishnan S. The Plasma Glycome Differences Between Women with PCOS and Healthy Controls. International Journal of Molecular Sciences. 2026;27(5):2350. doi:10.3390/ijms27052350
BibTeX
@article{Holman2026,
author = {Holman, Madison and Li, Sophie Jie and Ahern, Mary M and Ruhaak, L Renee and Karakas, Siddika and Krishnan, Sridevi},
title = {The Plasma Glycome Differences Between Women with PCOS and Healthy Controls},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {5},
pages = {2350},
doi = {10.3390/ijms27052350}
}
EUVIMED